Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

Caregivers can be barriers to tech-savvy seniors

Family caregivers are unintentional barriers to technology adoption and usage by older adults in their care even though they acknowledge it can be an important way of enriching the care recipient's life.

Thumbnail

GAO finds HIT deficiencies affecting patient care

Veterans' healthcare is being impacted by health IT deficiencies, according to a report from the Government Accountability Office. 

Thumbnail

Finding a way

This week we heard from two national coordinators for health IT.

ONC brief: HIT has improved patient safety

Health IT has resulted in more benefits than harm, according to a blog post on the Office of the National Coordinator for Health IT's blog, Health IT Buzz. 

Thumbnail

ATA: 'Telemedicine hitting the zenith'

Congressional action, expanding coverage and greater investment are all driving increasing use of telehealth, according to the latest "This Month in Telemedicine" talk from the American Telemedicine Association.

HX360 announces winners of inaugural challenge

HX360 announced the winners of the inaugural HX360 Innovation Challenge competition, recognizing the best-in-class digital health companies demonstrating improved patient experience in hospital and health system settings.  

Blumenthal: Address interoperability, outdated privacy and security regulations

Former National Coordinator for Health IT David Blumenthal, MD, penned a blog in the Wall Street Journal's "The Experts" addressing the potential for health IT as well as challenges related to interoperability and outdated privacy and security regulations. 

Ochsner augments hypertension program with Apple Watch

Ochsner Health System, based in New Orleans, La., will use the new Apple Watch to manage patients with chronic diseases. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.